Skip to main content

Apnimed, Inc.

APMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001745648

In the last 90 days, Apnimed, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding APMD, Q2 2026

See all superinvestors

No superinvestor reported holding APMD in Q2 2026.